BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34580437)

  • 1. Autoimmmune hepatitis.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    Cell Mol Immunol; 2022 Feb; 19(2):158-176. PubMed ID: 34580437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 autoimmune hepatitis: Genetic susceptibility.
    Lapierre P; Alvarez F
    Front Immunol; 2022; 13():1025343. PubMed ID: 36248826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
    Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
    Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
    Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
    Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hepatitis: a classic autoimmune liver disease.
    Moy L; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):341-6. PubMed ID: 25466500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile autoimmune hepatitis: A comprehensive review.
    Sokollik C; McLin VA; Vergani D; Terziroli Beretta-Piccoli B; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():69-76. PubMed ID: 30344030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
    Zachou K; Rigopoulou E; Dalekos GN
    J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
    Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
    J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria of autoimmune hepatitis.
    Liberal R; Grant CR; Longhi MS; Mieli-Vergani G; Vergani D
    Autoimmun Rev; 2014; 13(4-5):435-40. PubMed ID: 24418295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
    Djilali-Saiah I; Fakhfakh A; Louafi H; Caillat-Zucman S; Debray D; Alvarez F
    J Hepatol; 2006 Dec; 45(6):844-50. PubMed ID: 17050030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
    Dalekos GN; Zachou K; Liaskos C; Gatselis N
    Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
    Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review.
    Floreani A; Liberal R; Vergani D; Mieli-Vergani G
    J Autoimmun; 2013 Oct; 46():7-16. PubMed ID: 24035197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
    Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J
    Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis.
    Vergani D; Longhi MS; Bogdanos DP; Ma Y; Mieli-Vergani G
    Semin Immunopathol; 2009 Sep; 31(3):421-35. PubMed ID: 19533129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hepatitis.
    Longhi MS; Mieli-Vergani G; Vergani D
    Curr Pediatr Rev; 2014; 10(4):268-74. PubMed ID: 25403636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.